AIHW logo

METEOR logo

Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs

Site Navigation

  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources
Your session is about to end!
Your session will expire at [TIME]
Select Extend at the top right corner or you will be logged out

Person—cancer screening test result, bowel cancer code N[A]

Data Element Attributes

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termBowel cancer screening test result
METEOR identifier:Help on this term530020
Registration status:Help on this term

Health, Standard 29/08/2014

Definition:Help on this termThe outcome of the person's bowel cancer screening test, as represented by a code.
Data Element Concept:Help on this termPerson—cancer screening test result
Value Domain:Help on this termBowel cancer screening test result code N[A]

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termString
Format:Help on this termN[A]
Maximum character length:Help on this term2
  ValueMeaning
Permissible values:Help on this term1Positive
  2Negative
  3Inconclusive
  4No result
  1FPositive - faulty
  2FNegative - faulty
  3FInconclusive - faulty
  4F
 
No result - faulty
 

Collection and usage attributes

Guide for use:Help on this term

Bowel cancer screening typically involves the application of a faecal occult blood test (FOBT), in which FOBT are tested in a laboratory for the presence of blood.

CODE 1   Positive

Blood was detected in either faecal sample.

CODE 2   Negative

Blood was not detected in either faecal sample.

CODE 3   Inconclusive

Only one faecal sample was taken and it was negative.

CODE 4   No result

No result was detected in either faecal sample.

CODE 1F   Positive - faulty

Blood was detected in either faecal sample, however the test provided was inaccurate and results should be disregarded.

CODE 2F   Negative - faulty

Blood was not detected in either faecal sample, however the test provided was inaccurate and results should be disregarded.

CODE 3F   Inconclusive - faulty

Only one faecal sample was taken and it was negative, however the test provided was inaccurate and results should be disregarded.

CODE 4F   No result - faulty

No result was detected in either faecal sample, however the test provided was inaccurate and results should be disregarded.

Data element attributes Help on this term

Relational attributes

Implementation in Data Set Specifications:Help on this term
Bowel cancer screening test cluster

Health, Superseded 16/01/2020

DSS specific attributes +
DSS specific information:

A faecal occult blood test (FOBT) screening test is:

  • positive if blood was detected in either sample
  • negative if blood was not detected in either sample
  • inconclusive if only one sample was taken and it was negative
  • no result if screening test could not be analysed.

Other screening tests, when they become available, may have different indications for positive results. However, a positive result with any screening test is one that means further investigations are required.

Participants with a positive result are encouraged to visit their primary health care professional to follow up this finding. Those with an inconclusive result are requested to complete another FOBT kit, while those with a negative result are reminded that it is recommended they rescreen every two years.

At this stage, the screening pathway does not account for false negatives or positives.


Bowel cancer screening test cluster

Health, Superseded 05/02/2021

DSS specific attributes +
DSS specific information:

A faecal occult blood test (FOBT) screening test is:

  • positive if blood was detected in either sample
  • negative if blood was not detected in either sample
  • inconclusive if only one sample was taken and it was negative
  • no result if screening test could not be analysed.

Other screening tests, when they become available, may have different indications for positive results. However, a positive result with any screening test is one that means further investigations are required.

Participants with a positive result are encouraged to visit their primary health care professional to follow up this finding. Those with an inconclusive result are requested to complete another FOBT kit, while those with a negative result are reminded that it is recommended they rescreen every two years.

At this stage, the screening pathway does not account for false negatives or positives.


Bowel cancer screening test cluster

Health, Standard 05/02/2021

DSS specific attributes +
DSS specific information:

A faecal occult blood test (FOBT) screening test is:

  • positive if blood was detected in either sample
  • negative if blood was not detected in either sample
  • inconclusive if only one sample was taken and it was negative
  • no result if screening test could not be analysed.

Other screening tests, when they become available, may have different indications for positive results. However, a positive result with any screening test is one that means further investigations are required.

Participants with a positive result are encouraged to visit their primary health care professional to follow up this finding. Those with an inconclusive result are requested to complete another FOBT kit, while those with a negative result are reminded that it is recommended they rescreen every two years.

At this stage, the screening pathway does not account for false negatives or positives.


Implementation in Indicators:Help on this term
Used as Numerator
National Bowel Cancer Screening Program: PI 02-Screening positivity rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 02-Screening positivity rate

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 03-Diagnostic assessment rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 03-Diagnostic assessment rate

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 04-Time between positive screen and diagnostic assessment

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 04-Time between positive screen and diagnostic assessment

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 05b-Positive predictive value of diagnostic assessment for detecting adenoma

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 05b-Positive predictive value of diagnostic assessment for detecting adenoma

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 06b-Positive predictive value of diagnostic assessment for detecting colorectal cancer

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 06b-Positive predictive value of diagnostic assessment for detecting colorectal cancer

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 09-Adverse events (hospital admission rate)

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 09-Adverse events (hospital admission rate)

Health, Superseded 06/09/2018

Used as Disaggregation
National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Standard 06/09/2018

Used as Denominator
National Bowel Cancer Screening Program: PI 03-Diagnostic assessment rate

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 03-Diagnostic assessment rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 05b-Positive predictive value of diagnostic assessment for detecting adenoma

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 05b-Positive predictive value of diagnostic assessment for detecting adenoma

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 06b-Positive predictive value of diagnostic assessment for detecting colorectal cancer

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 06b-Positive predictive value of diagnostic assessment for detecting colorectal cancer

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 07-Interval cancer rate

Health, Superseded 06/09/2018

National Bowel Cancer Screening Program: PI 09-Adverse events (hospital admission rate)

Health, Standard 06/09/2018

National Bowel Cancer Screening Program: PI 09-Adverse events (hospital admission rate)

Health, Superseded 06/09/2018

<Title>

<body>
<footer>

View

  • Show more
  • Print view

Download

  • Word
  • PDF
  • Advanced options

Review

  • Compare items
Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

Terms & Conditions
Do you agree with the Terms and Conditions?

<Title>

<body>
<footer>
Loading...

Navigation

  • Find metadata
  • Metadata management
  • How to use METEOR
  • Learn about metadata

Resources

  • Accessibility
  • Terms and Conditions
  • Copyright
  • Disclaimer
  • Freedom of Information
  • Privacy policy
  • Vulnerability and disclosure policy

Quick Links

  • Contact
  • API
  • FAQs
  • Search
AIHW logo
© Australian Institute of Health and Welfare, 2026